{"id":350170,"date":"2025-08-25T19:09:10","date_gmt":"2025-08-25T19:09:10","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-blueprint-medicines-corporation\/"},"modified":"2025-08-25T19:09:10","modified_gmt":"2025-08-25T19:09:10","slug":"how-to-buy-blueprint-medicines-corporation","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/","title":{"rendered":"Blueprint Medicines Corporation (BPMC) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Blueprint Medicines Corporation (BPMC) Hisse Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334108,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-350170","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Blueprint Medicines Corporation (BPMC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Blueprint Medicines Corporation (BPMC) Hisse Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Blueprint Medicines Corporation (BPMC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Blueprint Medicines Corporation (BPMC) Hisse Yat\u0131r\u0131m\u0131"},"description":"Blueprint Medicines Corporation (BPMC) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131, g\u00fcncel fiyat analizini, 2025-2030 tahminlerini ve bu biyotek hisse al\u0131m hedefi i\u00e7in yat\u0131r\u0131m stratejilerini \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Blueprint Medicines Corporation (BPMC) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131, g\u00fcncel fiyat analizini, 2025-2030 tahminlerini ve bu biyotek hisse al\u0131m hedefi i\u00e7in yat\u0131r\u0131m stratejilerini \u00f6\u011frenin."},"intro":"Biyoteknolojinin en heyecan verici sat\u0131n alma hikayelerinden birine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Blueprint Medicines Corporation (BPMC), bilimsel yenilik ile stratejik kurumsal eylemin m\u00fckemmel birle\u015fimini temsil ediyor. Sanofi'nin 9,5 milyar dolarl\u0131k sat\u0131n alma s\u00fcreci devam ederken, bu hisse hem k\u0131sa vadeli yat\u0131r\u0131mc\u0131lar hem de uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in benzersiz f\u0131rsatlar sunuyor. Bu b\u00fcy\u00fcleyici biyotek oyunuyla ilgili bilmeniz gereken her \u015feyi birlikte inceleyelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Biyoteknolojinin en heyecan verici sat\u0131n alma hikayelerinden birine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Blueprint Medicines Corporation (BPMC), bilimsel yenilik ile stratejik kurumsal eylemin m\u00fckemmel birle\u015fimini temsil ediyor. Sanofi'nin 9,5 milyar dolarl\u0131k sat\u0131n alma s\u00fcreci devam ederken, bu hisse hem k\u0131sa vadeli yat\u0131r\u0131mc\u0131lar hem de uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in benzersiz f\u0131rsatlar sunuyor. Bu b\u00fcy\u00fcleyici biyotek oyunuyla ilgili bilmeniz gereken her \u015feyi birlikte inceleyelim."},"body_html":"<h2>\ud83d\udcc8 Blueprint Medicines Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>25 A\u011fustos 2025 itibar\u0131yla Blueprint Medicines Corporation (BPMC) <strong>129,46 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor - tam olarak Sanofi'nin sat\u0131n alma teklif fiyat\u0131nda. Ancak bunu \u00f6zellikle ilgin\u00e7 k\u0131lan \u015fey \u015fudur: Hisse senedi zaten Temmuz ortas\u0131nda 52 haftal\u0131k en y\u00fcksek seviyesi olan 129,65 $'a ula\u015ft\u0131 ve sat\u0131n alma fiyat\u0131 etraf\u0131nda inan\u0131lmaz bir istikrar g\u00f6sterdi.<\/p> <p><strong>Takviminize not edin: Ekim 2025 kritik.<\/strong> Blueprint Medicines'in bir sonraki kazan\u00e7 raporunu a\u00e7\u0131klamas\u0131 bekleniyor. Tarihsel olarak, bu biyotek kazan\u00e7 raporlar\u0131 \u00f6nemli fiyat hareketlerine neden olur.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 BPMC Hissesini Nas\u0131l Hareket Ettirir<\/h3> <p>Son tarihleri inceledi\u011fimizde net bir desen g\u00f6r\u00fcl\u00fcyor:<\/p> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Fiyat Etkisi<\/th><th>S\u00fcre<\/th><\/tr> <\/thead> <tbody> <tr><td>1 May\u0131s 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>%8,11 art\u0131\u015f<\/td><td>3 i\u015flem g\u00fcn\u00fc<\/td><\/tr> <tr><td>13 \u015eubat 2025<\/td><td>2024 4. \u00c7eyrek Sonu\u00e7lar\u0131<\/td><td>%6,3 kazan\u00e7<\/td><td>1 hafta<\/td><\/tr> <tr><td>30 Ekim 2024<\/td><td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>%4,2 d\u00fc\u015f\u00fc\u015f<\/td><td>Hedefler ka\u00e7\u0131r\u0131ld\u0131<\/td><\/tr> <tr><td>1 A\u011fustos 2024<\/td><td>2. \u00c7eyrek Raporu<\/td><td>%5,8 art\u0131\u015f<\/td><td>Tahminleri a\u015ft\u0131<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Bilgisi<\/strong>: Pozitif s\u00fcrprizler an\u0131nda %5-8 s\u0131\u00e7ramalar yarat\u0131rken, hedef ka\u00e7\u0131rmalar k\u0131sa vadeli %3-5 d\u00fczeltmelere neden olur. Sat\u0131n alma haberi son zamanlarda volatiliteyi 129 $ teklif fiyat\u0131 etraf\u0131nda stabilize etti.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h2> <p>Blueprint Medicines hisseleri son alt\u0131 ayda <strong>%77 etkileyici kazan\u00e7<\/strong> sa\u011flad\u0131:<\/p> <ul> <li><strong>\u015eubat 2025<\/strong>: ~73,04 $ (4. \u00e7eyrek kazan\u00e7 d\u00fc\u015f\u00fc\u015f\u00fc sonras\u0131)<\/li> <li><strong>Nisan 2025<\/strong>: ~98,60 $ (52 haftal\u0131k ortalamaya yakla\u015f\u0131rken)<\/li> <li><strong>Haziran 2025<\/strong>: 128,20 $ (sat\u0131n alma duyurusu s\u0131\u00e7ramas\u0131)<\/li> <li><strong>Temmuz 2025<\/strong>: 129,36 $ (t\u00fcm zamanlar\u0131n en y\u00fcksek seviyesi)<\/li> <li><strong>A\u011fustos 2025<\/strong>: 129,46 $ (sat\u0131n alma fiyat\u0131nda istikrarl\u0131)<\/li> <\/ul> <p>Bu b\u00fcy\u00fck y\u00fckseli\u015fin nedeni? \u00dc\u00e7 ana fakt\u00f6r:<\/p> <ol> <li><strong>Sanofi sat\u0131n alma haberi<\/strong> (<a href=\"https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2025\/2025-06-02-05-00-00-3091541\">2 Haziran duyurusu<\/a>)<\/li> <li><strong>2025 ilk yar\u0131da %55,5 gelir art\u0131\u015f\u0131<\/strong><\/li> <li><strong>AYVAKIT ticari ba\u015far\u0131s\u0131<\/strong> g\u00fcveni art\u0131r\u0131yor<\/li> <\/ol> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <h3>K\u0131sa Vadeli (2025)<\/h3> <p><strong>G\u00fcncel Fiyat<\/strong>: 129,46 $<br> <strong>2025 4. \u00c7eyrek Hedefi<\/strong>: 135-145 $<br> <strong>Karar<\/strong>: G\u00dc\u00c7L\u00dc AL - Sat\u0131n alma taban sa\u011flar, kazan\u00e7 potansiyeli mevcut<\/p> <h3>2026 Tahmini<\/h3> <p><strong>Fiyat Aral\u0131\u011f\u0131<\/strong>: 140-160 $<br> <strong>Gerek\u00e7e<\/strong>: Sat\u0131n alma sonras\u0131 entegrasyon tamamland\u0131, gelir b\u00fcy\u00fcmesi devam ediyor<\/p> <h3>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/h3> <p><strong>Projeksiyon Aral\u0131\u011f\u0131<\/strong>: 125-135 $<br> <strong>Analiz<\/strong>: Sanofi \u00e7at\u0131s\u0131 alt\u0131nda istikrarl\u0131 b\u00fcy\u00fcme, \u00fcr\u00fcn hatt\u0131 geli\u015fimi<\/p> <h3>2030 Vizyonu<\/h3> <p><strong>Hedef Fiyat<\/strong>: 121-128 $<br> <strong>Uzun vadeli<\/strong>: Olgun \u00fcr\u00fcn portf\u00f6y\u00fc, s\u00fcrd\u00fcr\u00fclebilir kazan\u00e7lar<\/p> <p><strong>Genel Tavsiye<\/strong>: Sat\u0131n alma arbitraj\u0131 ve k\u0131sa vadeli kazan\u00e7lar i\u00e7in AL<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Y\u00fcksek volatilite<\/strong> (Beta 1,36 - piyasadan %36 daha volatil)<\/li> <li><strong>Negatif kazan\u00e7lar<\/strong> (Hisse ba\u015f\u0131 kazan\u00e7 -2,51, \u00d6zsermaye getirisi -47,71%)<\/li> <li><strong>Bor\u00e7 endi\u015feleri<\/strong> (642,1 milyon $ bor\u00e7, ancak 615,5 milyon $ nakit ile dengeleniyor)<\/li> <li><strong>\u0130la\u00e7 sekt\u00f6r\u00fcnde d\u00fczenleyici engeller<\/strong><\/li> <li><strong>Sat\u0131n alma sonras\u0131 Sanofi ile entegrasyon riskleri<\/strong><\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Sanofi taraf\u0131ndan 9,5 milyar $ sat\u0131n alma<\/strong> ve hisse ba\u015f\u0131 129 $ (<a href=\"https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2025\/2025-07-18-05-00-00-3117709\">18 Temmuz'da tamamland\u0131<\/a>)<\/li> <li><strong>Y\u0131ll\u0131k %55,5 gelir art\u0131\u015f\u0131<\/strong><\/li> <li><strong>AYVAKIT ba\u015far\u0131s\u0131<\/strong> - 2030'a kadar 2 milyar $ hedefi<\/li> <li><strong>Ko\u015fullu De\u011fer Haklar\u0131<\/strong> ile ek 6 $\/hisse potansiyeli<\/li> <li><strong>Sekt\u00f6r trendi<\/strong>: Hassas t\u0131p y\u0131ll\u0131k %11 b\u00fcy\u00fcyor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>Stratejik al\u0131m yap\u0131n<\/strong> - Sat\u0131n alma fiyat taban\u0131 nedeniyle dolar maliyeti ortalamas\u0131 kullan\u0131n<\/li> <li><strong>S\u0131k\u0131 stoplar belirleyin<\/strong> - Volatilite nedeniyle %5-7 aras\u0131 risk y\u00f6netimi gereklidir<\/li> <li><strong>Ekim kazan\u00e7lar\u0131n\u0131 izleyin<\/strong> - Hareket i\u00e7in potansiyel kataliz\u00f6r<\/li> <li><strong>Dengeli \u00e7e\u015fitlendirme yap\u0131n<\/strong> - Biyotek portf\u00f6y dengesi gerektirir<\/li> <\/ol> <p>Esprili bir yorum: \"BPMC ticareti yapmak, bir ila\u00e7 klinik denemesini izlemek gibidir - %90 beklemek, %10 dramatik hareket. Ekim kazan\u00e7 g\u00f6sterisi i\u00e7in patlam\u0131\u015f m\u0131s\u0131r getirin!\"<\/p> <h2>\u2705 Blueprint Medicines Corporation (BPMC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ hisseleri ve rekabet\u00e7i \u00fccretler sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Hisse ticareti i\u00e7in KYC gereksinimleri standartt\u0131r<\/td><\/tr> <tr><td>3<\/td><td>Fon yat\u0131r\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"BPMC\" aramas\u0131 yap\u0131n<\/td><td>Blueprint Medicines i\u00e7in tam sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>129-130 $ aral\u0131\u011f\u0131nda limit emirler \u00f6nerilir<\/td><\/tr> <tr><td>6<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Komisyon oranlar\u0131n\u0131 kontrol edin<\/td><\/tr> <tr><td>7<\/td><td>Pozisyonu izleyin<\/td><td>Kazan\u00e7 ve haberler i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option, BPMC gibi hisselerde i\u015flem yapmak i\u00e7in \u00e7e\u015fitli avantajlar sunar:<\/p> <ul> <li><strong>Minimum depozito<\/strong>: Stratejileri test etmek i\u00e7in sadece 5 $<\/li> <li><strong>H\u0131zl\u0131 do\u011frulama<\/strong>: Tek belge ile KYC s\u00fcreci dakikalar s\u00fcrer<\/li> <li><strong>\u00c7oklu para \u00e7ekme se\u00e7enekleri<\/strong>: Kripto ve e-c\u00fczdanlar dahil 100'den fazla y\u00f6ntem<\/li> <li><strong>Kullan\u0131c\u0131 dostu platform<\/strong>: Hisse ticareti temellerini \u00f6\u011frenmek i\u00e7in ideal<\/li> <li><strong>E\u011fitim kaynaklar\u0131<\/strong>: S\u00fcrekli \u00f6\u011frenim i\u00e7in <a href=\"\/blog\">Pocket Option bloguna<\/a> eri\u015fim<\/li> <\/ul> <h2>\ud83c\udf0d 2025'te Blueprint Medicines: Biyoteknolojide Hassasiyetin \u00d6nc\u00fcs\u00fc<\/h2> <p>Blueprint Medicines, hedefe y\u00f6nelik tedavi platformuyla hassas t\u0131p alan\u0131nda liderdir. \u015eirketin amiral gemisi ilac\u0131 AYVAKIT (avapritinib), sistemik mastositoz hastalar\u0131n\u0131n tedavisinde devrim yaratm\u0131\u015ft\u0131r. Sanofi sat\u0131n almas\u0131 tamamland\u0131ktan sonra Blueprint, yenilik\u00e7i Ar-Ge odakl\u0131 yap\u0131s\u0131n\u0131 korurken k\u00fcresel ticari altyap\u0131dan faydalanmaktad\u0131r.<\/p> <p><strong>2025 ilgin\u00e7 ger\u00e7ek<\/strong>: Sat\u0131n alma g\u00f6r\u00fc\u015fmeleri s\u0131ras\u0131nda Blueprint'in bilim insanlar\u0131, BLU-808 bile\u015fi\u011finin alerji tedavisinde yeniden kullan\u0131labilece\u011fini ke\u015ffettiler - bu bulgu Sanofi anla\u015fmas\u0131na \u00f6nemli de\u011fer katt\u0131 ve \u015firketin yenilik\u00e7i k\u00fclt\u00fcr\u00fcn\u00fc g\u00f6steriyor.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Blueprint Medicines Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>25 A\u011fustos 2025 itibar\u0131yla Blueprint Medicines Corporation (BPMC) <strong>129,46 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor &#8211; tam olarak Sanofi&#8217;nin sat\u0131n alma teklif fiyat\u0131nda. Ancak bunu \u00f6zellikle ilgin\u00e7 k\u0131lan \u015fey \u015fudur: Hisse senedi zaten Temmuz ortas\u0131nda 52 haftal\u0131k en y\u00fcksek seviyesi olan 129,65 $&#8217;a ula\u015ft\u0131 ve sat\u0131n alma fiyat\u0131 etraf\u0131nda inan\u0131lmaz bir istikrar g\u00f6sterdi.<\/p>\n<p><strong>Takviminize not edin: Ekim 2025 kritik.<\/strong> Blueprint Medicines&#8217;in bir sonraki kazan\u00e7 raporunu a\u00e7\u0131klamas\u0131 bekleniyor. Tarihsel olarak, bu biyotek kazan\u00e7 raporlar\u0131 \u00f6nemli fiyat hareketlerine neden olur.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 BPMC Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<p>Son tarihleri inceledi\u011fimizde net bir desen g\u00f6r\u00fcl\u00fcyor:<\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Fiyat Etkisi<\/th>\n<th>S\u00fcre<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1 May\u0131s 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>%8,11 art\u0131\u015f<\/td>\n<td>3 i\u015flem g\u00fcn\u00fc<\/td>\n<\/tr>\n<tr>\n<td>13 \u015eubat 2025<\/td>\n<td>2024 4. \u00c7eyrek Sonu\u00e7lar\u0131<\/td>\n<td>%6,3 kazan\u00e7<\/td>\n<td>1 hafta<\/td>\n<\/tr>\n<tr>\n<td>30 Ekim 2024<\/td>\n<td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>%4,2 d\u00fc\u015f\u00fc\u015f<\/td>\n<td>Hedefler ka\u00e7\u0131r\u0131ld\u0131<\/td>\n<\/tr>\n<tr>\n<td>1 A\u011fustos 2024<\/td>\n<td>2. \u00c7eyrek Raporu<\/td>\n<td>%5,8 art\u0131\u015f<\/td>\n<td>Tahminleri a\u015ft\u0131<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Bilgisi<\/strong>: Pozitif s\u00fcrprizler an\u0131nda %5-8 s\u0131\u00e7ramalar yarat\u0131rken, hedef ka\u00e7\u0131rmalar k\u0131sa vadeli %3-5 d\u00fczeltmelere neden olur. Sat\u0131n alma haberi son zamanlarda volatiliteyi 129 $ teklif fiyat\u0131 etraf\u0131nda stabilize etti.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h2>\n<p>Blueprint Medicines hisseleri son alt\u0131 ayda <strong>%77 etkileyici kazan\u00e7<\/strong> sa\u011flad\u0131:<\/p>\n<ul>\n<li><strong>\u015eubat 2025<\/strong>: ~73,04 $ (4. \u00e7eyrek kazan\u00e7 d\u00fc\u015f\u00fc\u015f\u00fc sonras\u0131)<\/li>\n<li><strong>Nisan 2025<\/strong>: ~98,60 $ (52 haftal\u0131k ortalamaya yakla\u015f\u0131rken)<\/li>\n<li><strong>Haziran 2025<\/strong>: 128,20 $ (sat\u0131n alma duyurusu s\u0131\u00e7ramas\u0131)<\/li>\n<li><strong>Temmuz 2025<\/strong>: 129,36 $ (t\u00fcm zamanlar\u0131n en y\u00fcksek seviyesi)<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: 129,46 $ (sat\u0131n alma fiyat\u0131nda istikrarl\u0131)<\/li>\n<\/ul>\n<p>Bu b\u00fcy\u00fck y\u00fckseli\u015fin nedeni? \u00dc\u00e7 ana fakt\u00f6r:<\/p>\n<ol>\n<li><strong>Sanofi sat\u0131n alma haberi<\/strong> (<a href=\"https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2025\/2025-06-02-05-00-00-3091541\">2 Haziran duyurusu<\/a>)<\/li>\n<li><strong>2025 ilk yar\u0131da %55,5 gelir art\u0131\u015f\u0131<\/strong><\/li>\n<li><strong>AYVAKIT ticari ba\u015far\u0131s\u0131<\/strong> g\u00fcveni art\u0131r\u0131yor<\/li>\n<\/ol>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<h3>K\u0131sa Vadeli (2025)<\/h3>\n<p><strong>G\u00fcncel Fiyat<\/strong>: 129,46 $<br \/> <strong>2025 4. \u00c7eyrek Hedefi<\/strong>: 135-145 $<br \/> <strong>Karar<\/strong>: G\u00dc\u00c7L\u00dc AL &#8211; Sat\u0131n alma taban sa\u011flar, kazan\u00e7 potansiyeli mevcut<\/p>\n<h3>2026 Tahmini<\/h3>\n<p><strong>Fiyat Aral\u0131\u011f\u0131<\/strong>: 140-160 $<br \/> <strong>Gerek\u00e7e<\/strong>: Sat\u0131n alma sonras\u0131 entegrasyon tamamland\u0131, gelir b\u00fcy\u00fcmesi devam ediyor<\/p>\n<h3>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/h3>\n<p><strong>Projeksiyon Aral\u0131\u011f\u0131<\/strong>: 125-135 $<br \/> <strong>Analiz<\/strong>: Sanofi \u00e7at\u0131s\u0131 alt\u0131nda istikrarl\u0131 b\u00fcy\u00fcme, \u00fcr\u00fcn hatt\u0131 geli\u015fimi<\/p>\n<h3>2030 Vizyonu<\/h3>\n<p><strong>Hedef Fiyat<\/strong>: 121-128 $<br \/> <strong>Uzun vadeli<\/strong>: Olgun \u00fcr\u00fcn portf\u00f6y\u00fc, s\u00fcrd\u00fcr\u00fclebilir kazan\u00e7lar<\/p>\n<p><strong>Genel Tavsiye<\/strong>: Sat\u0131n alma arbitraj\u0131 ve k\u0131sa vadeli kazan\u00e7lar i\u00e7in AL<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Y\u00fcksek volatilite<\/strong> (Beta 1,36 &#8211; piyasadan %36 daha volatil)<\/li>\n<li><strong>Negatif kazan\u00e7lar<\/strong> (Hisse ba\u015f\u0131 kazan\u00e7 -2,51, \u00d6zsermaye getirisi -47,71%)<\/li>\n<li><strong>Bor\u00e7 endi\u015feleri<\/strong> (642,1 milyon $ bor\u00e7, ancak 615,5 milyon $ nakit ile dengeleniyor)<\/li>\n<li><strong>\u0130la\u00e7 sekt\u00f6r\u00fcnde d\u00fczenleyici engeller<\/strong><\/li>\n<li><strong>Sat\u0131n alma sonras\u0131 Sanofi ile entegrasyon riskleri<\/strong><\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Sanofi taraf\u0131ndan 9,5 milyar $ sat\u0131n alma<\/strong> ve hisse ba\u015f\u0131 129 $ (<a href=\"https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2025\/2025-07-18-05-00-00-3117709\">18 Temmuz&#8217;da tamamland\u0131<\/a>)<\/li>\n<li><strong>Y\u0131ll\u0131k %55,5 gelir art\u0131\u015f\u0131<\/strong><\/li>\n<li><strong>AYVAKIT ba\u015far\u0131s\u0131<\/strong> &#8211; 2030&#8217;a kadar 2 milyar $ hedefi<\/li>\n<li><strong>Ko\u015fullu De\u011fer Haklar\u0131<\/strong> ile ek 6 $\/hisse potansiyeli<\/li>\n<li><strong>Sekt\u00f6r trendi<\/strong>: Hassas t\u0131p y\u0131ll\u0131k %11 b\u00fcy\u00fcyor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>Stratejik al\u0131m yap\u0131n<\/strong> &#8211; Sat\u0131n alma fiyat taban\u0131 nedeniyle dolar maliyeti ortalamas\u0131 kullan\u0131n<\/li>\n<li><strong>S\u0131k\u0131 stoplar belirleyin<\/strong> &#8211; Volatilite nedeniyle %5-7 aras\u0131 risk y\u00f6netimi gereklidir<\/li>\n<li><strong>Ekim kazan\u00e7lar\u0131n\u0131 izleyin<\/strong> &#8211; Hareket i\u00e7in potansiyel kataliz\u00f6r<\/li>\n<li><strong>Dengeli \u00e7e\u015fitlendirme yap\u0131n<\/strong> &#8211; Biyotek portf\u00f6y dengesi gerektirir<\/li>\n<\/ol>\n<p>Esprili bir yorum: &#8220;BPMC ticareti yapmak, bir ila\u00e7 klinik denemesini izlemek gibidir &#8211; %90 beklemek, %10 dramatik hareket. Ekim kazan\u00e7 g\u00f6sterisi i\u00e7in patlam\u0131\u015f m\u0131s\u0131r getirin!&#8221;<\/p>\n<h2>\u2705 Blueprint Medicines Corporation (BPMC) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ hisseleri ve rekabet\u00e7i \u00fccretler sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Hisse ticareti i\u00e7in KYC gereksinimleri standartt\u0131r<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;BPMC&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>Blueprint Medicines i\u00e7in tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>129-130 $ aral\u0131\u011f\u0131nda limit emirler \u00f6nerilir<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Komisyon oranlar\u0131n\u0131 kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Pozisyonu izleyin<\/td>\n<td>Kazan\u00e7 ve haberler i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option, BPMC gibi hisselerde i\u015flem yapmak i\u00e7in \u00e7e\u015fitli avantajlar sunar:<\/p>\n<ul>\n<li><strong>Minimum depozito<\/strong>: Stratejileri test etmek i\u00e7in sadece 5 $<\/li>\n<li><strong>H\u0131zl\u0131 do\u011frulama<\/strong>: Tek belge ile KYC s\u00fcreci dakikalar s\u00fcrer<\/li>\n<li><strong>\u00c7oklu para \u00e7ekme se\u00e7enekleri<\/strong>: Kripto ve e-c\u00fczdanlar dahil 100&#8217;den fazla y\u00f6ntem<\/li>\n<li><strong>Kullan\u0131c\u0131 dostu platform<\/strong>: Hisse ticareti temellerini \u00f6\u011frenmek i\u00e7in ideal<\/li>\n<li><strong>E\u011fitim kaynaklar\u0131<\/strong>: S\u00fcrekli \u00f6\u011frenim i\u00e7in <a href=\"\/blog\">Pocket Option bloguna<\/a> eri\u015fim<\/li>\n<\/ul>\n<h2>\ud83c\udf0d 2025&#8217;te Blueprint Medicines: Biyoteknolojide Hassasiyetin \u00d6nc\u00fcs\u00fc<\/h2>\n<p>Blueprint Medicines, hedefe y\u00f6nelik tedavi platformuyla hassas t\u0131p alan\u0131nda liderdir. \u015eirketin amiral gemisi ilac\u0131 AYVAKIT (avapritinib), sistemik mastositoz hastalar\u0131n\u0131n tedavisinde devrim yaratm\u0131\u015ft\u0131r. Sanofi sat\u0131n almas\u0131 tamamland\u0131ktan sonra Blueprint, yenilik\u00e7i Ar-Ge odakl\u0131 yap\u0131s\u0131n\u0131 korurken k\u00fcresel ticari altyap\u0131dan faydalanmaktad\u0131r.<\/p>\n<p><strong>2025 ilgin\u00e7 ger\u00e7ek<\/strong>: Sat\u0131n alma g\u00f6r\u00fc\u015fmeleri s\u0131ras\u0131nda Blueprint&#8217;in bilim insanlar\u0131, BLU-808 bile\u015fi\u011finin alerji tedavisinde yeniden kullan\u0131labilece\u011fini ke\u015ffettiler &#8211; bu bulgu Sanofi anla\u015fmas\u0131na \u00f6nemli de\u011fer katt\u0131 ve \u015firketin yenilik\u00e7i k\u00fclt\u00fcr\u00fcn\u00fc g\u00f6steriyor.<\/p>\n"},"faq":[{"question":"Blueprint Medicines hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, fon yat\u0131r\u0131n, \"BPMC\" sembol\u00fcn\u00fc aray\u0131n, uygun sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in ve i\u015flemi onaylay\u0131n."},{"question":"Sanofi'nin Blueprint Medicines'i sat\u0131n almas\u0131 ne anlama geliyor?","answer":"Sanofi'nin 9,5 milyar dolarl\u0131k sat\u0131n almas\u0131, Blueprint'in k\u00fcresel ticari altyap\u0131dan faydalanmas\u0131n\u0131 sa\u011flar ve hisse fiyat\u0131nda istikrar yarat\u0131r."},{"question":"BPMC hissesi i\u00e7in 2025-2030 fiyat tahmini nedir?","answer":"2025 i\u00e7in 135-145 $, 2026 i\u00e7in 140-160 $, 2028 i\u00e7in 125-135 $ ve 2030 i\u00e7in 121-128 $ aral\u0131\u011f\u0131nda fiyatlar \u00f6ng\u00f6r\u00fclmektedir."},{"question":"BPMC hissesi yat\u0131r\u0131m\u0131nda hangi riskler vard\u0131r?","answer":"Y\u00fcksek volatilite, negatif kazan\u00e7lar, bor\u00e7 endi\u015feleri, d\u00fczenleyici engeller ve entegrasyon riskleri ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar BPMC hissesi al\u0131rken nelere dikkat etmeli?","answer":"Stratejik al\u0131m yapmal\u0131, s\u0131k\u0131 stoplar belirlemeli, Ekim kazan\u00e7 raporlar\u0131n\u0131 takip etmeli ve portf\u00f6y\u00fc dengeli tutmal\u0131d\u0131r."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Blueprint Medicines hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, fon yat\u0131r\u0131n, \"BPMC\" sembol\u00fcn\u00fc aray\u0131n, uygun sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in ve i\u015flemi onaylay\u0131n."},{"question":"Sanofi'nin Blueprint Medicines'i sat\u0131n almas\u0131 ne anlama geliyor?","answer":"Sanofi'nin 9,5 milyar dolarl\u0131k sat\u0131n almas\u0131, Blueprint'in k\u00fcresel ticari altyap\u0131dan faydalanmas\u0131n\u0131 sa\u011flar ve hisse fiyat\u0131nda istikrar yarat\u0131r."},{"question":"BPMC hissesi i\u00e7in 2025-2030 fiyat tahmini nedir?","answer":"2025 i\u00e7in 135-145 $, 2026 i\u00e7in 140-160 $, 2028 i\u00e7in 125-135 $ ve 2030 i\u00e7in 121-128 $ aral\u0131\u011f\u0131nda fiyatlar \u00f6ng\u00f6r\u00fclmektedir."},{"question":"BPMC hissesi yat\u0131r\u0131m\u0131nda hangi riskler vard\u0131r?","answer":"Y\u00fcksek volatilite, negatif kazan\u00e7lar, bor\u00e7 endi\u015feleri, d\u00fczenleyici engeller ve entegrasyon riskleri ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar BPMC hissesi al\u0131rken nelere dikkat etmeli?","answer":"Stratejik al\u0131m yapmal\u0131, s\u0131k\u0131 stoplar belirlemeli, Ekim kazan\u00e7 raporlar\u0131n\u0131 takip etmeli ve portf\u00f6y\u00fc dengeli tutmal\u0131d\u0131r."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Blueprint Medicines Corporation (BPMC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Blueprint Medicines Corporation (BPMC) Hisse Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Blueprint Medicines Corporation (BPMC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Blueprint Medicines Corporation (BPMC) Hisse Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T19:09:10+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Blueprint Medicines Corporation (BPMC) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Blueprint Medicines Corporation (BPMC) Hisse Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T19:09:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/\"},\"wordCount\":20,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/\",\"name\":\"Blueprint Medicines Corporation (BPMC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Blueprint Medicines Corporation (BPMC) Hisse Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"datePublished\":\"2025-08-25T19:09:10+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Blueprint Medicines Corporation (BPMC) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Blueprint Medicines Corporation (BPMC) Hisse Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Blueprint Medicines Corporation (BPMC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Blueprint Medicines Corporation (BPMC) Hisse Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/","og_locale":"tr_TR","og_type":"article","og_title":"Blueprint Medicines Corporation (BPMC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Blueprint Medicines Corporation (BPMC) Hisse Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T19:09:10+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Blueprint Medicines Corporation (BPMC) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Blueprint Medicines Corporation (BPMC) Hisse Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T19:09:10+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/"},"wordCount":20,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/","name":"Blueprint Medicines Corporation (BPMC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Blueprint Medicines Corporation (BPMC) Hisse Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","datePublished":"2025-08-25T19:09:10+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Blueprint Medicines Corporation (BPMC) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Blueprint Medicines Corporation (BPMC) Hisse Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":350173,"slug":"how-to-buy-blueprint-medicines-corporation","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Blueprint Medicines Corporation (BPMC) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Blueprint Medicines Corporation (BPMC)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/"},"pt_AA":{"locale":"pt_AA","id":350172,"slug":"how-to-buy-blueprint-medicines-corporation","post_title":"Como comprar a\u00e7\u00f5es da Blueprint Medicines Corporation (BPMC) - Investimento em a\u00e7\u00f5es da Blueprint Medicines Corporation (BPMC)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/350170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=350170"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/350170\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334108"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=350170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=350170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=350170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}